BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27644645)

  • 21. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia.
    Yamazaki J; Taby R; Vasanthakumar A; Macrae T; Ostler KR; Shen L; Kantarjian HM; Estecio MR; Jelinek J; Godley LA; Issa JP
    Epigenetics; 2012 Feb; 7(2):201-7. PubMed ID: 22395470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation.
    Sohni A; Bartoccetti M; Khoueiry R; Spans L; Vande Velde J; De Troyer L; Pulakanti K; Claessens F; Rao S; Koh KP
    Mol Cell Biol; 2015 Mar; 35(6):1026-42. PubMed ID: 25582196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
    Jia JS; Salvatore S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):273-8. PubMed ID: 23628015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation of the promoter region of the MTRR gene in childhood acute lymphoblastic leukemia.
    Bai J; Li L; Li Y; Chen Q; Zhang L; Xie X
    Oncol Rep; 2019 Jun; 41(6):3488-3498. PubMed ID: 31002356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer.
    Rawłuszko-Wieczorek AA; Siera A; Horbacka K; Horst N; Krokowicz P; Jagodziński PP
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1379-92. PubMed ID: 25557833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.
    Schäfer V; Ernst J; Rinke J; Winkelmann N; Beck JF; Hochhaus A; Gruhn B; Ernst T
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1641-50. PubMed ID: 27169594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
    Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
    Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATM promoter analysis in childhood lymphoid malignancies: a brief communication.
    Gumy-Pause F; Wacker P; Maillet P; Betts DR; Sappino AP
    Leuk Res; 2006 Mar; 30(3):335-7. PubMed ID: 16125772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.
    Stumpel DJ; Schneider P; van Roon EH; Boer JM; de Lorenzo P; Valsecchi MG; de Menezes RX; Pieters R; Stam RW
    Blood; 2009 Dec; 114(27):5490-8. PubMed ID: 19855078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.
    Agirre X; Román-Gómez J; Vázquez I; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Artieda P; Cordeu L; Lahortiga I; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
    Int J Cancer; 2006 Apr; 118(8):1945-53. PubMed ID: 16287063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TET2 promotor methylation and TET2 protein expression in pediatric posterior fossa ependymoma.
    Pierscianek D; Teuber-Hanselmann S; Ahmadipour Y; Darkwah Oppong M; Unteroberdörster M; Müller O; Jabbarli R; Sure U; Zhu Y; El Hindy N
    Neuropathology; 2020 Apr; 40(2):138-143. PubMed ID: 31777116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
    Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia.
    Mai H; Liu X; Chen Y; Li C; Cao L; Chen X; Chen S; Liu G; Wen F
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):497-504. PubMed ID: 26501552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
    Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
    Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J
    J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demethylation of the RB1 promoter concomitant with reactivation of TET2 and TET3 impairs gastric carcinogenesis in K19-Wnt1/C2mE transgenic mice.
    Cao D; Jia Z; Wu Y; Su T; Zhao D; Wu M; Tsukamoto T; Oshima M; Jiang J; Cao X
    Life Sci; 2020 Dec; 263():118580. PubMed ID: 33058920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.
    Yamazaki J; Taby R; Jelinek J; Raynal NJ; Cesaroni M; Pierce SA; Kornblau SM; Bueso-Ramos CE; Ravandi F; Kantarjian HM; Issa JP
    J Natl Cancer Inst; 2015 Nov; 108(2):. PubMed ID: 26568194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.
    Rahmani M; Talebi M; Hagh MF; Feizi AAH; Solali S
    Biomed Pharmacother; 2018 Jan; 97():1493-1500. PubMed ID: 29793312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.